Akso Health Group
NASDAQ:AHGFinancial - Credit Services
+$0.03 today
- Market cap
- $1.16B
- Beta
- -1.02
- P/E (TTM)
- -3.1
- EPS (TTM)
- -$0.40
Volume 0.00M
Average 0.12M
AHG Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Akso Health GroupNASDAQ: AHG
Cash & Equivalents · Q2 FY2026 · quarter ended Sep 2025
Cash & equivalents falls 87.8% from a year ago
Cash & equivalents stood at $11.13M at the end of Q2 FY2026, down 87.8% from a year earlier. Over 3 fiscal years it compounded at +112.3% a year.
Context
- Cash & equivalents amounted to 5.2% of total assets at the end of Q2 FY2026, down 37.7 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -87.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 176.23M USD
- Year-over-year change
- +106.9%
- 4-year CAGR
- +84.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-03-31 | 176.23M | +106.9% |
| FY2024 | 2024-03-31 | 85.17M | +974.8% |
| FY2023 | 2023-03-31 | 7.92M | -57.0% |
| FY2022 | 2022-03-31 | 18.43M | +21.8% |
| FY2021 | 2021-03-31 | 15.13M | — |
Cash & Equivalents vs competitors
How AHG compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -87.8% is the lowest of 4, against a peer median of -0.3%.
- Cash & equivalents amounts to 5.2% of total assets for AHG, versus a peer median of 40.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CN¥5.49B CNY | +2.0% | +2.8% | 40.2% | |
ZKHZKH Group Limited | Mar 2026 | CN¥1.07B CNY | -5.5% | -17.6% | 17.2% |
| Mar 2026 | $61.46M USD | -0.3% | +2.3% | 54.9% | |
| Sep 2025 | $11.13M USD | -87.8% | +112.3% | 5.2% | |
| Peer median (excluding AHG) | — | -0.3% | +2.3% | 40.2% | |
Competitors are the stored peer set for AHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Mar 2021 | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 15.13M | 18.43M | 7.92M | 85.17M | 176.23M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 14.4M | 20M | 9.23M | 0 | 12.9M |
| Inventory | 0 | 7.8M | 1.69M | 191.2K | 190.24K |
| Other Current Assets | 0 | 16.23M | 1.62M | 402.9K | 6.81M |
| Total Current Assets | 30.12M | 62.63M | 20.46M | 142.02M | 196.12M |
| Property, Plant & Equipment (Net) | 66.89K | 55.43K | 0 | 0 | 114.54K |
| Goodwill | 0 | 0 | 0 | 0 | 10.83M |
| Intangible Assets | 0 | 0 | 0 | 0 | 7.88M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.5M | 121.54K | 0 | 0 | 0 |
| Total Non-current Assets | 1.56M | 176.98K | 0 | 0 | 18.83M |
| Total Assets | 31.69M | 62.81M | 20.46M | 142.02M | 214.95M |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 10M | 0 | 0 | 0 | 0 |
| Tax Payables | 302.68K | 92.82K | 96.01K | 74.09K | 33.86K |
| Deferred Revenue | 0 | 0 | 194.38K | 415.02K | 10.22M |
| Other Current Liabilities | 0 | 13M | 705.48K | 0 | 0 |
| Total Current Liabilities | 14.41M | 50.52M | 11.62M | 3.59M | 13.81M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 1.95M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 0 | 0 | 0 | 0 | 1.99M |
| Total Liabilities | 14.41M | 50.52M | 11.62M | 3.59M | 15.8M |
| Common Stock | 5K | 6.98K | 6.98K | 43.83K | 165.68K |
| Retained Earnings | (36.26M) | (53.11M) | (54.47M) | (63.93M) | (198.9M) |
| Accumulated OCI | (3.1M) | (1.65M) | (3.85M) | (4.09M) | (3.77M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 1.98K | 114.21K | 56.81K | 31.99K |
| Total Equity | 17.27M | 12.29M | 8.84M | 138.42M | 199.15M |
| Total Debt | 10M | 0 | 0 | 0 | 81.74K |
| Net Debt | (5.13M) | (18.43M) | (7.92M) | (85.17M) | (176.15M) |
Akso Health Group
NASDAQ:AHG
Intrinsic Alpha fair value
Locked
Current Price
$1.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.